// App-Quantinova.ai

Sa1564 : Heparin Replacement Was the Most Significant Risk of Delayed Bleeding in Gastric ESD by Multivariate Analysis of Anti-Thrombotic Therapy, Comorbidities and Characteristics of Tumors

Researchers

Presenter

  • Tsutomu Nishida

Principal Investigators

  • Naoki Kawai

  • Kiyonori Yuguchi

  • Takuya Yamada

  • Shinji Kitamura

  • Masato Komori

  • Tomoki Michida

  • Hideki Iijima

  • Masahiko Tsujii

  • Tetsuo Takehara

Medical Centers

  • Osaka Koseinenkin Hospital, Osaka, Japan

  • Osaka Rousai Hospital, Osaka, Japan

  • Osaka National Hospital, Osaka, Japan

  • Osaka Rousai Hospital, Osaka, Japan

  • Osaka University Graduate School of Medicine, Suita, Japan

  • Sakai City Hospital, Sakai, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic kidney disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Ticlopidine Hydrochloride

  • Warfarin

  • Heparin

  • Suloctidil

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved